Adamas Pharmaceuticals reported -5636000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Acadia Pharmaceuticals ACAD:US $ -15.3M 28.41M
Acorda Therapeutics ACOR:US $ -23.01M 7.32M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Aerie Pharmaceuticals AERI:US $ -32.37M 0.87M
Aptinyx Inc APTX:US $ -21206000 1.34M
Biocryst Pharmaceuticals BCRX:US $ -44.58M 15M
Flexion Therapeutics FLXN:US $ -23658000 6.78M
GlaxoSmithKline GSK:LN 1.94B 263M
Glaxosmithkline GSK:US $ 1938M 263M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Heron Therapeutics HRTX:US $ -51.71M 8.76M
Intra Cellular Therapies ITCI:US $ -77.32M 8.18M
Marinus Pharmaceuticals MRNS:US $ -19.17M 4.32M
Merk MRK:US $ 4826M 3212M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Novartis NOVN:VX 3.23B 246M
Omeros OMER:US $ -18253000 5.76M
Prothena PRTA:US 109.23M 81.28M
Revance Therapeutics RVNC:US $ -72723000 2.39M
Teva Pharmaceutical TEVA:IT 623M 41M
Zogenix ZGNX:US $ -53.87M 1.56M